Farringdon Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-407	Closed	-$258K	–	568
2025 Q1	$258K	Buy	+407	New	+$258K	0.13%	236